Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06710873

Analysis of Clinical Application of China's First Batch of TYRX Absorbable Antibacterial Envelope

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study is the first to use TYRX domesticly, reporting and summarizing its usage to validate its real-world effectiveness in CIED infection prevention.

Detailed description

This study is the first to use TYRX domesticly, reporting and summarizing its usage to validate its real-world effectiveness in CIED infection prevention.

Conditions

Interventions

TypeNameDescription
DEVICETYRX Absorbable Antibacterial EnvelopeAll enrolled patients will receive the TYRX Absorbable Antibacterial Envelope implanted simultaneously during the CIED surgery.

Timeline

Start date
2023-12-01
Primary completion
2024-10-09
Completion
2026-03-01
First posted
2024-11-29
Last updated
2025-03-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06710873. Inclusion in this directory is not an endorsement.

Analysis of Clinical Application of China's First Batch of TYRX Absorbable Antibacterial Envelope (NCT06710873) · Clinical Trials Directory